In this cohort, only 30% of patients had a BRAF V600 mutation, which represents the higher age of our cohort, since in the elderly there is a lower percentage of BRAF V600 mutations in melanoma [25]; in the total population, approximately 50% of MBM patients have a BRAF V600 mutation [24]. This evidence concerns the gene BRAF and melanoma.